People

Search Language

日本語 / Japanese | Use language selector above (below, on mobile) to search additional languages
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(Technology & Innovation)
  • x(知的財産)
  • clear all

42 items matching filters

Search Results

320059

Practice:

  • Technology & Innovation Sector
  • International Arbitration & Dispute Resolution
  • 知的財産
  • Trade Secrets Litigation

Amy Van Zant パートナー

シリコン・バレー

For her litigation practice, Amy’s ability to distill the most complicated technology across an array of fields, including telecommunications, semiconductor manufacturing, renewable energy, cloud computing, and big data, into relatable, every day concepts that has made her successful in persuading judges and juries alike. She has led trial teams, litigated, and tried cases in state court in California, numerous District Courts, the International Trade Commission, and has briefed appeals before the 9th Circuit, the Federal Circuit, the Supreme Court of California, and the United States Supreme Court. 

Whether litigating patent, trade secret, or IP contract disputes, Amy strives to put herself in her client’s shoes to ensure personalized results tailored to each client’s business objectives. As SAP’s General Counsel Landon Edmond commented to Acritas, Amy “has acquired a great knowledge of our business, and therefore you know you can trust her in a wide variety of topics and to get the right colleagues within her firm involved across the globe.”

Amy also provides comprehensive IP counseling on issues including trade secrets protection, employee departure investigations, freedom to operate analysis, licensing strategies, data privacy protection, and regulatory compliance. She has also conducted comprehensive patent portfolio reviews and assisted with IP corporate transactions.

In addition to her IP work, Amy devotes significant time to her pro bono work. For more than a decade, she has assisted domestic violence victims, as well as led Orrick’s Bay Area summer program that enables law clerks to be certified to argue in Family Court to obtain Temporary Restraining Orders for domestic violence clients.

195894

Practice:

  • Technology & Innovation Sector
  • 知的財産
  • Cyber, Privacy & Data Innovation
  • Patents
  • Trade Secrets Litigation
  • IP相談およびデューデリジェンス
  • Mass Torts & Product Liability
  • Antitrust & Competition
  • International Trade and Investment
  • White Collar, Investigations, Securities Litigation & Compliance
  • Employment Law & Litigation
  • Trademark, Copyright & Media
  • China

Xiang Wang パートナー

北京; New York

ワン博士は、電気工学・コンピュータ工学の博士号、中国法の学位、米国ニューヨーク州およびインディアナ州での法曹資格を有し、米国特許庁に登録しているという数少ない経歴を持つ知的財産権弁護士として高い評価を得ており、中国国内屈指の知的財産関連の法務を提供している。中国に本拠を置く海外企業が関与した、訴訟と仲裁両方での特許紛争において成功を収めたことにより、オリックの中国知的財産チームは、China Central Television (CCTV)によって特集され、「Patent Wars」と題された30分のドキュメンタリー映画が2011年10月29日に放送された。

代表的な知的財産関連の案件 

  • 中国で事業に従事する企業の大規模な特許・商標ポートフォリオの出願・登録手続き、強制執行、および技術移転/ライセンス供与契約。
  • 中国および米国の両国におけるオフィスアクション、異議申立て、および特許の無効性に関する訴訟手続き、模造品・海賊版防止の取り組み、特許・商標の強制執行訴訟。
  • 企業秘密、輸出規制、産業スパイ活動に関わる国境を越えた訴訟。
  • 米国国際貿易委員会の下でのITC第337条関連訴訟。
  • 製造物責任と欠陥商品回収。
  • 米国地方裁判所における証券集団訴訟および米国証券取引委員会(SEC)と司法省(DOJ)により発議された調査や審理を含む、米国に登録している中国企業の監査委員会による調査やその他の調査事項に関連して取締役会やその企業を代理。
  • 中国国家食品薬品監督管理局(SFDA)および米国食品医薬品局(FDA)への届出、薬品および装置の輸入登録免許、中国のGMP(医薬品製造品質管理規範)およびGSP(医薬品経営品質管理規範)、保険還付、その他の政府および規制当局の問題、臨床試験、CRO契約およびOEM契約における援助等を含む、中国および米国の両国における規制遵守および訴訟手続きにおいて医療機器製造会社および製薬会社の代理。
  • 技術移転契約およびOEM契約、研究開発や製造に関する合弁事業および戦略的パートナーシップ。
  • 知的財産に関連するデュー・ディリジェンスおよびポートフォリオに関するカウンセリング。
  • 中国における検閲問題、データ守秘権と保護に関しソーシャルメディア会社を援助。

ワン博士の実践的な法的助言は、弁護士になる以前の10年以上に及ぶ医療機器および電子装置の両業界での経験の成果といえる。さらにワン博士は本人の名で医療技術に関する米国特許を4件取得している。これらの業界における経験には以下が含まれる。

  • 米系医療技術コンサルティング会社のアジアサービス担当マネージング・ディレクター、米系医療機器製造会社のシニアコンサルタント兼科学諮問評議会メンバー、米系医療機器製造会社の研究開発担当エグゼクティブ・ディレクター、米国の大手病院外科手術部門の医療研究担当ディレクター、米系大手医療機器製造会社2社のソフトウェア・エンジニアおよびシステム・アナリスト、北京の中日友好医院のバイオメディカル・エンジニア。
  • 上記の役職において、医療機器の開発、指示、製造;パートナー企業の選択、調査、および交渉;PMA およびFDA 510(k) に関する申請書の整理、助言、および編集;FDA、UL 544、CSA、およびその他の規制の監督および遵守;臨床試験の設計および遂行。

ワン博士は、中国において事業に従事する企業に影響を及ぼす知的財産権に関する法規制およびクロスボーダー関係の構築および進展の先導役として広く認められている。現在、上海の米国商工会議所知的財産委員会副会長、および中国のR&D-based Pharmaceutical Associationの法律顧問を務める。さらに、米国ペンシルベニア州フィラデルフィア市のドレクセル大学の機械工学およびバイオメディカル・エンジニアリングの客員教授でもある。

著書・著作

  • 60を上回る書籍および業界紙の論説の著者または共著者である。最近では中国の医療機器および医薬品に関する新規制要件ならびに中国および米国で事業を展開しつつ知的財産を保護する方法に関する記事を著す。

講演およびプログラム

  • 米国と中国における特許、商標、企業秘密紛争、および製造物責任訴を含む、知的財産保護の方法に関して国際セミナーやコンファレンスにおいて頻繁に講演している。
  • クロスボーダー知的財産問題に関する新聞やニュースメディアによるインタビュー多数(例:The New York Times、The Wall Street Journal、Reuters、Bloomberg、International Herald Tribune、Financial Times、Law 360、Asian Legal Business、China Central Television (CCTV programs 「Dialogue」、「China Insight」、および米国証券訴訟に関するプログラム「Crossover」、ドキュメンタリー映画「Patent Wars」および「Digital Rights」)、China Radio International、China Business Law JournalM、Chinese Lawyer、people.com.cn、Caixin Media、Chicago Herald、Managing Intellectual Property、Asia IP、CFO Innovations、並びにSwedish Broadcasting Corporation)。
740

Practice:

  • Technology & Innovation Sector
  • 知的財産
  • Patents
  • Trademark, Copyright & Media
  • Trade Secrets Litigation
  • China

Carol Yan シニア・アソシエイト

北京

Carol’s practice focuses on patent filing and prosecution, patent-related legal advice and patent litigation across a broad range of industries, including chemistry, materials science, pharmaceutical, biotechnology, medical device, semiconductor and auto mechanics. Carol has extensional experience in patent, trademark, domain name, copyright and trade secret.

Before joining Orrick, Carol worked with Lung Tin International Property Agent Ltd. and in Jones Day’s Beijing Office.

Practice:

  • Technology & Innovation Sector
  • Technology Transactions
  • Technology Companies Group
  • IP相談およびデューデリジェンス
  • 知的財産
  • Mergers and Acquisitions
  • Strategic Advisory and Government Enforcement

Daniel Yost パートナー

サンフランシスコ; シリコン・バレー

Highly regarded for his expertise, Chambers USA has ranked Daniel for his expertise in Technology Transactions and noted that “His work is solution-driven and his positive personality helps both sides of a negotiation work towards the outcome.” Legal 500 describes his practice as “exceptional” and recommends the practice for its “high client service ethic and great commercial awareness." He is known for his ability to handle complex transactions for science-based technology companies, with work ranging from intellectual property and licensing to distribution agreements and cross-border collaborations, counseling clients on commercial law, copyright, licensing, marketing, patent, privacy, strategic alliances, trademark and trade secrets matters.

Daniel has represented companies in various industries, including biotechnology, cleantech, energy, consumer electronics, entertainment, hardware, internet, media, semiconductor, services, software, telecommunications and wireless. His energy clients include clients in the solar, biofuels, waste to energy and geothermal sectors.

Daniel has acted as key legal counsel in:

  • Manufacturing, distribution and sale arrangements for makers of software, chips, security devices, batteries and solar technologies, among others.
  • Technology transactions with universities, governments and non-profit entities.
  • Copyright, privacy and online pitfalls applicable to Internet companies.
  • Domestic and international collaborations for developers of pharmaceutical products, medical devices, semiconductors and software, among others.
  • Mergers, acquisitions, spin-offs and asset divestitures in a wide range of industries, including biotechnology, health databases, semiconductors medical software, entertainment, Internet browsers and e-commerce.
  • Open software source policy development and compliance.
  • IT and business process services agreements.
  • Venture capital investments in technology-based enterprises.

The former co-chair of both the Technology Transactions and Technology Companies Practice Groups, Daniel is a thought leader on technology transactions issues and programs that focus on the protection and exploitation of intellectual property, having advised on clients such as Weta Digital, Fulcrum BioEnergy, CelLink Corporation, Telenor, Luminar, and Motorola Solutions. He is regularly called up to speak about intellectual property and technology matters and has done so at UC Berkeley, Stanford and other universities and conferences. His work on incentivizing innovation has been published in major papers, including Forbes, the Daily Journal San Francisco and the San Jose Mercury News.

Daniel’s current volunteer work includes serving on the Board of Joint Venture Silicon Valley, the Advisory Counsel for UC Berkeley’s Center for Law, Energy and the Environment and California Environmental Voters. Daniel also advises state and local elected officials on policies to encourage the development and deployment of zero emissions technologies. Daniel’s prior volunteer work includes serving as Mayor and Councilmember in Woodside, California and serving as a founding Board Member of Peninsula Clean Energy – the community choice energy provider serving San Mateo County.

Practice:

  • Technology & Innovation Sector
  • 知的財産

Jason Yu パートナー

シリコン・バレー

Jason has represented technology companies in multiple venues, including various state and federal courts, the International Trade Commission, and the Patent and Trademark office. His matters span different technological areas including, Information Technology, satellite communications, semiconductor manufacturing, circuit design and verification tools, image texture and graphics processing, gaming, and a variety of software products.
740

Practice:

  • Technology & Innovation Sector
  • 知的財産
  • Patents
  • Trademark, Copyright & Media
  • Trade Secrets Litigation
  • China

Shelley Zhang パートナー

北京

Shelley's related IP experience includes the following:

  • Patent invalidation proceedings, anti-counterfeiting, anti-piracy efforts and patent and trademark enforcement litigation in China.
  • Prosecution of patent and trademark, including application preparation, office actions/oppositions procedures and reexamination procedures.
  • Enforcement and technology transfer/licensing arrangements for substantial patent and trademark portfolios for companies doing business in China.
  • Advising on IP protection strategies, R&D related IP issues and matters in relation to export and import control of technology.
  • Assisting Chinese companies in Section 337 U.S. International Trade Commission investigations, patent infringement litigations and product liability litigations in the U.S. 
  • IP due diligence and portfolio counseling.